peptide elongation factor 2 has been researched along with Down Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fountoulakis, M; Freidl, M; Gulesserian, T; Lubec, B; Lubec, G | 1 |
1 other study(ies) available for peptide elongation factor 2 and Down Syndrome
| Article | Year |
|---|---|
Deterioration of the transcriptional, splicing and elongation machinery in brain of fetal Down syndrome.
Topics: Brain; Down Syndrome; Electrophoresis, Gel, Two-Dimensional; Female; Fetus; Gene Expression Regulation, Developmental; Humans; Male; Peptide Elongation Factor 1; Peptide Elongation Factor 2; Peptide Elongation Factor Tu; Protein Biosynthesis; Proteome; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-crk; RNA Splicing; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Transcription, Genetic | 2001 |